2.8 % increased from year 2016 in Baht 76.5 million of which Baht 2,707.5 million were revenue from sales. The company had successfully recorded a sales growth of Baht 67.9 million, or 2.6 %. Please
the issuer’s core business. In any event, the issuer must not operate business in such a way that involves severely illegal business. For example, human trafficking, drug production or smuggling, or
, the company and its subsidiaries have the total assets valued Baht 16,503.0 million, as compared to the 2017, Baht 15,034.1 million, increased Baht 1,468.9 million as below detailed; 1. Cash and cash
subsidiaries have loss for the period of Baht 47.8 million, increased loss of Baht 249.2 million or 522% for the following main reasons; 1. The total sales has decreased of Baht 383.9 million, due to the export
as compared to a net profit of Baht 5.32 million posted in the Q1/2017, which was increased of Baht 1.41 million or 26.59 percent. Revenues Total Revenues The Company and its subsidiaries’ total
persons ) and related services i.e. registration with Food and Drug Administration (FDA), trademark permission, product and packaging design, and brand building etc. to customers who are business operator
transferred on share sale and purchase date from the seller’s connected persons ) and related services i.e. registration with Food and Drug Administration (FDA), trademark permission, product and packaging
. registration with Food and Drug Administration (FDA), trademark permission, product and packaging design, and brand building etc. to customers who are business operator in skin cares and cosmetics. In addition
granted a license from China Food and Drug Administration (CFDA) during the beginning of 2018 as the Company had to redesign and adjust product packaging according to the granted license as well as change
issued from China Food and Drug Administration (CFDA) at the beginning of 2018 as the Company had to redesign its packaging to comply with the requirements of the license and adjust its sales structures